Emergent BioSolutions Inc
EBS10.920USD
+0.350+3.32%
收盘 02/06, 16:00（美东）报价延迟15分钟
575.48M总市值
7.68市盈率 TTM
关于 Emergent BioSolutions Inc 公司
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc简介
公司代码EBS
公司名称Emergent BioSolutions Inc
上市日期Nov 15, 2006
CEOPapa (Joseph C)
员工数量900
证券类型Ordinary Share
年结日Nov 15
公司地址300 Professional Dr
城市GAITHERSBURG
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编20879
电话12406313200
网址https://emergentbiosolutions.com/
公司代码EBS
上市日期Nov 15, 2006
CEOPapa (Joseph C)
Emergent BioSolutions Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+60000.00%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
196.50K
-4995.00%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+34403.00%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
90.86K
-30608.00%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
88.44K
-3543.00%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
78.17K
-7100.00%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
68.39K
+62500.00%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
68.25K
+34403.00%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
66.14K
-7844.00%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
62.55K
-610.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+60000.00%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
196.50K
-4995.00%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+34403.00%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
90.86K
-30608.00%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
88.44K
-3543.00%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
78.17K
-7100.00%
收入明细
单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
MCM Product sales
142.50M
61.66%
Commercial Product sales
74.90M
32.41%
Contracts and grants
13.70M
5.93%
地区USD
名称
营收
占比
U.S.Government
133.00M
57.55%
Non-U.S Government
98.10M
42.45%
业务
地区
业务USD
名称
营收
占比
MCM Product sales
142.50M
61.66%
Commercial Product sales
74.90M
32.41%
Contracts and grants
13.70M
5.93%
股东统计
更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
6.77%
State Street Investment Management (US)
4.66%
American Century Investment Management, Inc.
4.54%
Dimensional Fund Advisors, L.P.
4.08%
其他
72.53%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
6.77%
State Street Investment Management (US)
4.66%
American Century Investment Management, Inc.
4.54%
Dimensional Fund Advisors, L.P.
4.08%
其他
72.53%
股东类型
持股股东
占比
Investment Advisor
35.49%
Investment Advisor/Hedge Fund
30.57%
Hedge Fund
7.40%
Individual Investor
2.97%
Research Firm
1.57%
Pension Fund
1.05%
Bank and Trust
0.60%
Sovereign Wealth Fund
0.18%
Family Office
0.07%
其他
20.10%
机构持股
更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
2023Q3
563
42.52M
113.85%
-6.21M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.90M
7.43%
+75.52K
+1.97%
Sep 30, 2025
The Vanguard Group, Inc.
3.54M
6.74%
-43.54K
-1.21%
Sep 30, 2025
State Street Investment Management (US)
2.45M
4.66%
+705.00K
+40.50%
Sep 30, 2025
American Century Investment Management, Inc.
2.38M
4.54%
+90.22K
+3.94%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.14M
4.08%
+291.31K
+15.75%
Sep 30, 2025
Palisade Capital Management, LLC
1.43M
2.72%
+326.26K
+29.67%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
1.38M
2.63%
+276.57K
+25.02%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.28M
2.43%
-305.00
-0.02%
Sep 30, 2025
Acadian Asset Management LLC
1.18M
2.24%
+203.07K
+20.84%
Sep 30, 2025
Connor, Clark & Lunn Investment Management Ltd.
1.13M
2.16%
+145.63K
+14.76%
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
查看更多
AdvisorShares Insider Advantage ETF
占比0.97%
Royce Quant Small-Cap Quality Value ETF
占比0.41%
State Street SPDR S&P Biotech ETF
占比0.28%
Federated Hermes MDT Small Cap Core ETF
占比0.23%
Harbor Human Capital Factor US Small Cap ETF
占比0.19%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.18%
Pacer US Small Cap Cash Cows ETF
占比0.16%
Invesco RAFI US 1500 Small-Mid ETF
占比0.15%
Avantis US Small Cap Value ETF
占比0.14%
iShares Micro-Cap ETF
占比0.13%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
